News Hub | News Direct

Healthcare

Addiction Biotech Cannabis Genetics Healthcare Medical Devices Pharmaceutical Science Veterinary
Article thumbnail News Release

Research Collaboration Validates MyAnIML’s AI-Powered, Facial Recognition Cattle Predictive Health Platform

MyAnIML

A collaborative study between animal agtech startup MyAnIML and the United States Department of Agriculture (USDA) successfully corroborated the technology's predictive ability to proactively manage devastating disease outbreaks in cattle production. MyAnIML used proprietary facial recognition and deep learning technology to accurately predict Infectious Bovine Keratoconjunctivitis (IBK), or bovine pinkeye, 99.4% of the time and several days before veterinarians were able to detect symptoms, according to published study results. USDA Agricultural Research Service scientists Mike Clawson and Larry Kuehn, who have researched IBK for years at the U.S. Meat Animal Research Center, shared their expertise on the project. “Early detection of disease is critical to healthy herd management – giving producers the chance to separate sick animals, control spread and judiciously use antibiotics before a large outbreak occurs,” said Mike Clawson, an USDA Agricultural Research Service molecular biologist and project researcher. “The results of the MyAnIML study demonstrate how far and how impactful AI-powered technology can be toward ensuring a safe, resilient and sustainable U.S. food supply chain.” The MyAnIML and USDA study included 870 beef cattle located on three different Kansas ranches during the summers of 2021 and 2022. Bovine pinkeye is highly contagious and the most common ocular disease of cattle globally, costing U.S. producers alone an estimated $150 million annually in lost performance and treatment costs. There are no effective vaccines for IBK, forcing producers to treat infected animals with antibiotics, thereby elevating the risk of developing antibiotic-resistance bacteria strains that threaten human health. Building off this collaboration, MyAnIML and USDA are applying the technology next to predict Bovine Respiratory Disease (BRD). As the single most economically impactful cattle disease, BRD costs the U.S. feedlot industry potentially more than $900 million annually, according to the American Society of Animal Science. “Building off our AI platform’s ability to distinguish between ‘healthy’ and ‘sick’ cattle two to three days before symptoms were diagnosed, the next step is expanding MyAnIML’s repertoire of diseases and health events to offer producers new tools to ensure a safe food supply,” said Shekhar Gupta, MyAnIML CEO and founder. MyAnIML’s patent-pending technology platform uses AI, facial recognition and inexpensive GoPro cameras to automatically capture and analyze subtle changes in a cow’s muzzle. Like a human fingerprint, each cattle muzzle is unique, and can be used to track specific cows. However, MyAnIML, is the first to use muzzle dermatoglyphics to not only identify cows, but as a health predictor of diseases such as BRD, IBK, foot root and uterine infections, proving that subtle changes in the bumps and ridges on a cow muzzle are a precursor of a health event. MyAnIML’s trial partners have also successfully used the technology to monitor the health status of cows going into estrus, early stages of labor and even subtle health stressors, like the need for more nutrition while nursing calves. "The muzzle is an incredible mirror into cattle health and well-being. Humans just didn’t have the ability to ‘see’ what the muzzle was telling us without the help of MyAnIML’s advanced AI and facial recognition technology,” Gupta said. Since its founding in 2021, MyAniML has: Developed a proprietary dataset of 3000 muzzle images of beef cattle, the first cattle facial and muzzle image library for health management. Partnered in trial projects with multiple Midwest cattle production facilities. Released an inexpensive Bluetooth-enabled “smart” ear tag and app that helps large-scale commercial feedlots and stockyards quickly locate potentially sick animals identified by the MyAnIML predictive platform. Signed a partnership agreement with DairyFi an India-based startup, in January. With 308 million cows, India has the largest cattle herd in the world, but suffers from lack of adequate cattle health services, greatly reducing the economic and productivity potential of India’s cattle industry. With positive results from the collaboration, large-scale trials, veterinarian feedback and ongoing product development, MyAnIML is getting ready for broad-scale commercialization. The company received angel investment funding in 2021 and is currently in the process of a seed funding investment round to expand its technology in cattle, as well as to include other livestock and companion animals. About MyAnIML MyAnIML invented and is commercializing the first-of-its-kind platform for early disease prediction in cattle using facial recognition technology focused on a cow’s muzzle. The initial discovery is the product of intense curiosity and a sense of purpose by the founder, a leading expert in generative AI and emerging uses of web-based blockchain technology. MyAnIML’s mission is to help ensure the health and well-being of cattle while ensuring an affordable and safe food supply. For more information www.myaniml.com. Contact Details AgTech PR Georgie Smith +1 360-929-0244 georgie@agtechpr.com Company Website https://www.myaniml.com

January 23, 2024 08:00 AM Central Standard Time

Image
Article thumbnail News Release

RZ Publish Nooro Foot Massager Reviews: Why It Is Used In The United States?

Spark Metro PR

Are you tired of living with constant burning and tingling in your feet due to neuropathy? Frustrated with painkillers that merely numb the discomfort without addressing the root cause? If so, you're not alone. Many have experienced the struggle of seeking relief from neuropathic pain, only to find temporary solutions. However, you are lucky to have come across this review because it is a comprehensive report about a breakthrough device popularly known as Nooro Foot Massager that goes beyond masking the symptoms, offering a chance to reverse nerve damage and regain a life free from persistent foot pain. In a world where traditional remedies may involve uncomfortable movements, Dr. Jeremy Campbell, in collaboration with the innovative med tech startup Nooro, introduces Nooro Foot Massager as a simple at-home solution for foot pain powered by Neuromuscular Electrical Stimulation (NMES) technology. This is where the story takes a turn towards hope and healing. Are you ready to break free from neuropathic pain and experience the relief you've been longing for? The Nooro Foot Massager might just be your key to a new lease on life. What Is Nooro Foot Massager? Nooro Foot Massager is a revolutionary at-home solution developed through the collaboration of Dr. Jeremy Campbell and the innovative med tech startup, Nooro. Designed to address neuropathic foot pain, Nooro Foot Massager device employs NeuroMuscular Electrical Stimulation (NMES) technology to offer relief in the comfort of your home. Specifically named the Nooro Foot Massager, this device stands out by delivering a unique combination of targeted electric impulses deep into the tissues of your feet and legs. The primary goal? To kickstart blood circulation, a crucial factor in providing the oxygen necessary for nerve recovery. By enhancing blood flow to your feet, the Nooro Foot Massager becomes a catalyst for nerve repair and healing. This breakthrough approach holds the promise of reducing the burning pain, tingling, and numbness associated with neuropathy. The ultimate result? A chance to reclaim the activities you love, free from the constant foot pain and swelling that may have confined you. This user-friendly device opens doors to a life where neuropathic pain no longer dictates your daily experiences, offering a pathway to comfort and mobility. In essence, the Nooro Foot Massager is more than just a device – it's a transformative tool designed to empower you on your journey to relief from neuropathic foot pain. CLICK HERE NOW TO GET THE NOORO FOOT MASSAGER DIRECTLY FROM THE OFFICIAL WEBSITE Features (Nooro Foot Massager Reviews USA) EMS Technology: The Nooro Foot Massager employs advanced NeuroMuscular Electrical Stimulation (EMS) technology. This technology facilitates the penetration of steady electric impulses deep into the tissues of the feet and legs, aiming to relieve muscle tension, increase blood circulation, and strengthen weakened muscles. Cordless Convenience: The Nooro EMS Foot Massager offers a cordless design, eliminating the hassle of dealing with tangled cords during use. Charging is simple using the provided electricity plug and cable, ensuring a convenient and clutter-free experience. Optional Preparatory Step: While optional, the recommendation to wash your feet and remove excess skin before using the massager adds a thoughtful touch. This preparatory step enhances the overall effectiveness of the massage treatment, promoting a more thorough and satisfying experience. Versatile Massage Modes: The device features a variety of different modes, providing users with options to cater to their specific needs. Whether you're looking to relax after a long day or target particular muscle groups causing discomfort, the Nooro Foot Massager's versatility ensures a customized and enjoyable experience. Adjustable Intensity Levels: Tailoring the massage experience to individual preferences, the massager offers a mind-bending number of speed settings. This wide range allows users to find the perfect intensity level, ensuring that the massage is both effective and comfortable for various muscle groups. User-Friendly Operation: The massager's simplicity is a standout feature. With easy-to-follow steps—place your feet on the foot pad, select the mode, and adjust intensity—you can initiate the massage effortlessly. The user-friendly design ensures that anyone can enjoy the benefits without a steep learning curve. Effective Neuropathy Relief: The Nooro Foot Massager is specifically designed to address neuropathic foot pain. By enhancing blood circulation, relieving muscle tension, and providing a targeted massage experience, the device aims to alleviate burning pain, tingling, and numbness. Users can experience liberation from the challenges of neuropathy, promoting overall foot health and well-being. Benefits Of Nooro Foot Massager Pain Alleviation: A primary benefit of the Nooro Foot Massager is its ability to ease neuropathic foot pain. By employing advanced EMS technology, the massager delivers targeted electric impulses to alleviate burning sensations and discomfort associated with neuropathy. Users may experience significant relief from persistent foot pain. Tingling Relief: This innovative EMS massager targets nerve-related tingling sensations by enhancing blood circulation. Through its unique combination of electric impulses, the Nooro Foot Massager aims to improve oxygen supply to peripheral nerves, reducing tingling and promoting a sense of comfort. Numbness Reduction: For individuals experiencing numbness due to neuropathy, the Nooro Foot Massager offers hope. By increasing blood flow to the feet and facilitating nerve repair, the device strives to reduce numbness, allowing users to regain sensation in their extremities. Improved Blood Circulation: A core benefit lies in the massager's ability to enhance blood circulation. The EMS technology stimulates blood flow to the feet and legs, ensuring a continuous supply of oxygen to nerve cells. Improved circulation contributes not only to pain relief but also to overall foot health. Muscle Strengthening: Beyond addressing neuropathic pain, the Nooro Foot Massager helps strengthen weakened muscles. The electric impulses penetrate deep into the tissues, promoting muscle stimulation. This additional benefit contributes to overall foot strength and may aid in preventing future discomfort. Convenience and Comfort: The cordless design, along with the straightforward operational steps, adds a layer of convenience to the user experience. The Nooro Foot Massager provides a hassle-free solution for those seeking comfort and relief. Users can enjoy the benefits of a personalized massage without the inconvenience of cords or complicated setup. How Does Nooro Foot Massager Work? (Nooro Foot Massager Reviews) The Nooro EMS Foot Massager operates on advanced EMS (Electrical Muscle Stimulation) technology, offering a multi-faceted approach to relieving discomfort. True to its name, using this device is as simple as placing your feet on it and letting it work its magic. Specifically, Nooro EMS Foot Massager works by increasing blood flow to your feet, the massager facilitates the delivery of much-needed oxygen to nerve cells. This groundbreaking approach opens the door to nerve repair and healing, reducing burning pain, tingling, and numbness. But here's the beauty of it – as long as your nerves are alive, there's hope for reversal. The National Institute of Health emphasizes the regenerative capacity of peripheral nerves when the underlying nerve cell remains intact. The Nooro Foot Massager becomes a tool for revitalization, offering relief and a chance to reclaim a life without constant foot pain. This innovative massager employs steady electric impulses that penetrate deep into your feet and legs, effectively targeting muscle tension. The result? Relaxation of tense muscles, which is essential for alleviating discomfort associated with neuropathic foot pain. What sets the Nooro Foot Massager apart is its versatility. With a variety of modes and an impressive array of speed settings, the device allows you to tailor your experience to address specific muscle groups. This flexibility ensures that you can find a satisfying combination, catering to the unique needs of whatever muscle group is causing you distress. In essence, the Nooro Foot Massager is designed to be user-friendly and customizable. Its cutting-edge EMS technology aims to enhance blood circulation, relieve muscle tension, and strengthen weakened muscles, all while providing a hassle-free experience. So, whether you're looking to unwind after a long day or target specific muscle groups causing discomfort, this device offers a personalized solution to meet your needs. Who Needs Nooro Foot Massager? Foot Pain and Discomfort: If your feet hurt or feel uncomfortable, the Nooro Foot Massager can give you relief and make you feel better. Plantar Fasciitis: If you have plantar fasciitis (pain in the bottom of your feet), using the massager can help ease the pain and make your feet more comfortable. Athletes and Runners: Athletes and runners can use the massager to relax their muscles and recover faster after exercising. Diabetes: If you have diabetes and your feet need extra care, the Nooro Foot Massager can be part of your routine to keep your feet comfortable. Swelling: If your feet are swollen, especially during pregnancy or due to certain health issues, the Nooro Foot Massager can help reduce the swelling. General Well-being: If you just want to feel better overall and more relaxed, using the Nooro Foot Massager can contribute to your well-being. CLICK HERE NOW TO GET THE NOORO FOOT MASSAGER DIRECTLY FROM THE OFFICIAL WEBSITE AT A MASSIVE DISCOUNT Does Nooro EMS Foot Massager Really Work? Absolutely, the Nooro EMS Foot Massager has garnered positive reviews from satisfied customers, attesting to its effectiveness. Users express genuine satisfaction with the relief it provides, particularly in addressing knee-related concerns. Many have reported that it contributes to a positive sensation in their knees, offering comfort and support, especially before bedtime. Customers dealing with foot pains have found solace in the Nooro Foot Massager. The device seems to provide tangible relief, soothing discomfort associated with foot pains. The positive feedback highlights the impact of the massager in helping alleviate foot-related issues, making it a promising solution for those seeking relief from foot pain. One user shared their experience, noting the immediate positive effects after just one use. This firsthand account emphasizes the rapid and noticeable benefits users can expect, further reinforcing the idea that the Nooro EMS Foot Massager indeed works to bring comfort and relief. In essence, the testimonials from customers reflect a consensus that the Nooro EMS Foot Massager is not just a device but a reliable solution that genuinely addresses pain and discomfort, particularly in the knees. The positive feedback from users reinforces the notion that the Nooro Foot Massager is effective in delivering the relief it promises. How To Use Nooro Foot Massager? Using the Nooro EMS Foot Massager is delightfully straightforward, making it a hassle-free addition to your routine. First and foremost, you'll appreciate the absence of annoying cords – charging is a breeze with the included electricity plug and cable that come with your order. Once charged, the process is as simple as 1-2-3. For an optimal experience, the second step is optional but recommended – give your feet a quick wash and remove any excess skin. This preparatory step significantly enhances the effectiveness of the massage treatment. Now, you're ready to indulge in the soothing benefits of the Nooro Foot Massager. Just place your feet on the foot pad, select your preferred mode, and adjust the intensity level of the massage to your liking. It's a customizable experience tailored to meet your unique needs. From there, all that's left to do is sit back comfortably and let the massager work its magic. As it eases pain, relieves tingling, and liberates you from the challenges of neuropathy, you'll find a newfound sense of comfort and relief. The Nooro Foot Massager brings simplicity and effectiveness together, making it a user-friendly solution for those seeking relief from neuropathic foot pain. Price Of Nooro Foot Massager And Where To Buy Nooro Foot Massager can be gotten directly from the manufacturer’s official website at the following prices: Single Unit: Buy one Nooro Foot Massager for $99.95. Two Units: Buy two Nooro Foot Massagers for $94.95 each. Total cost: $189.90. Three Units: Buy three Nooro Foot Massagers for $89.95 each. Total cost: $269.85. Four Units: Buy four Nooro Foot Massagers for $87.95 each. Total cost: $351.80. Six Units: Buy six Nooro Foot Massagers for $84.95 each. CLICK HERE NOW TO GET THE NOORO FOOT MASSAGER DIRECTLY FROM THE OFFICIAL WEBSITE Nooro Foot Massager Reviews Consumer Reports And Customer Complaints The Nooro EMS Foot Massager has received overwhelmingly positive consumer reports, with an impressive 4.8-star rating and a noteworthy achievement of zero customer complaints. Thousands of individuals have experienced successful outcomes in reversing neuropathy with this device, highlighting its efficacy and customer satisfaction. Harry Keegan - “Superb relaxation, it's not bulky, so you can take it anywhere, cheaper than other massagers, does what it says. You'll love the "cupping mode". Many intensity options (up to 19). It's a great product with fast shipping! My wife loves it…” Debra Peyton - “Should have bought Nooro Foot Massager earlier, exactly what I needed for my neuropathy-pained-feet. Honestly, I can walk and move with just minimal pain. I've only used it for like 2 days and I have felt better than I have in the past 2 years!!!” Clara Milton - “I absolutely love my Nooro EMS Foot Massager massager, had to get one for my daughter today since she wont stop using mine!” Final Verdict On Nooro EMS Foot Massager Reviews The overwhelming positive reviews and testimonials for the Nooro Foot Massager paint a compelling picture of its effectiveness and customer satisfaction. With a remarkable 4.8-star rating and zero customer complaints, it stands out as a reliable solution for those seeking relief from neuropathic foot pain. Customers like Harry Keegan commend the massager for its superb relaxation, portability, affordability, and diverse intensity options. The mention of the "cupping mode" adds to the device's appeal. Debra Peyton's experience reinforces the quick and tangible relief the Nooro Foot Massager provides, enabling her to walk with minimal pain after just two days of use. Clara Milton's enthusiasm and the decision to purchase an additional massager for her daughter further underscore the positive impact and effectiveness of the device. In the final verdict, the Nooro Foot Massager emerges as a standout product, praised for its user-friendly design, versatility, and ability to address neuropathy-induced foot pain. The absence of customer complaints reinforces its credibility, making it a promising choice for those in search of a reliable and effective solution to neuropathic pain. CLICK HERE NOW TO GET THE NOORO FOOT MASSAGER DIRECTLY FROM THE OFFICIAL WEBSITE Disclaimer: Please understand that any advice or guidelines revealed here are not even remotely substitutes for sound medical or financial advice from a licensed healthcare provider or certified financial advisor. Make sure to consult with a professional physician or financial consultant before making any purchasing decision if you use medications or have concerns following the review details shared above. Individual results may vary. These products are not intended to diagnose, treat, cure or prevent any disease and do not provide any kind of get-rich money scheme. Reviewer is not responsible for pricing inaccuracies. Check product sales page for final prices. Contact Details Review Zenith Alex +1 302-597-6768 Alexreview@gmail.com Company Website https://reviewzenith.com

January 22, 2024 09:33 AM Eastern Standard Time

Image
Article thumbnail News Release

Kadimastem and iTolerance Complete Initial Targeted Engagement for Regulatory Advice on CBER Products (INTERACT) Meeting with the U.S. FDA

Kadimastem

Ness Ziona, Israel, January 22, 2024, Kadimastem (TASE: KDST) and iTolerance Inc. announced today that the companies held a preliminary meeting with the INTERACT committee of the U.S Food and Drug Administration (FDA) on January 19 th, 2024 regarding the preclinical and clinical development leading toward commercialization of iTOL-102, a potential cure for diabetes that does not require chronic immune system suppression. Before the meeting, the companies received a response document from the FDA noting important feedback about the current preclinical plans which the companies intend to use for the advancement of their potential joint collaboration development plans. With the feedback from the INTERACT meeting received, the companies are working on the design and commencement of a clinical study of iTOL-102 that is planned to be submitted to the FDA for an IND in the future. Dr. Anthony Japour, Chief Executive Officer of iTolerance, commented, “We are pleased with the continued progress of our research collaboration with Kadimastem. With the INTERACT meeting now complete and the feedback received from our discussions with FDA, we are evaluating next steps toward a potentially innovative cure for patients with Type 1 diabetes.” Kadimastem CEO Asaf Shiloni said, " Thanks to our scientific teams who presented the joint collaboration project in an impressive manner. I am convinced that the helpful meeting and the relevant feedback will contribute to the continued progress of our planned joint product development and hopefully provide a cure for those living with diabetes.” In May 2023, the companies announced their research collaboration agreement to co-develop and commercialize a breakthrough and innovative regenerative technology to cure diabetes without the need for chronic immunosuppression and received a grant in the aggregate amount of US$1.0 million from the Binational Israel-U.S. Industrial R&D (BIRD) Foundation. As part of the agreement, the companies are considering expanding their cooperation and advancing the development of iTOL-102. The joint project is based on Kadimastem’s diabetes product called IsletRx, which is comprised of clinical-grade clusters of human pancreatic islet like cells (ILCs). Preclinical studies have shown that the cells are able to detect the sugar levels in the body and to produce and secrete dependently, the required amounts of insulin and glucagon, just like a healthy pancreas. iTolerance, headquartered in Miami, Florida, has developed an innovative platform technology (iTOL-100) intended to enable the transplantation of allogeneic cells without tissue matching and without the need for chronic treatments that suppress the immune system of the transplant recipient (immunosuppression). This platform technology was successfully demonstrated in preclinical experiments in large animals (non-human primates), where diabetes was cured by allogeneic transplantation, without the need for long-term immunosuppressive treatments. About Kadimastem Kadimastem is a clinical stage cell therapy company, developing "off-the-shelf", allogeneic, proprietary cell products based on its technology platform for the expansion and differentiation of Human Embryonic Stem Cells (hESCs) into functional cells. AstroRx®, the company's lead product, is an astrocyte cell therapy in clinical development for the treatment for ALS and in pre-clinical studies for other neurodegenerative indications. IsletRx is the company's treatment for diabetes. IsletRx is comprised of functional pancreatic islet cells producing and releasing insulin and glucagon, intended to treat and potentially cure patients with insulin-dependent diabetes. Kadimastem was founded by Professor Michel Revel, CSO of the company and Professor Emeritus of Molecular Genetics at the Weizmann Institute of Science. Professor Revel received the Israel Prize for the invention and development of Rebif®, a multiple sclerosis blockbuster drug sold worldwide. Kadimastem is traded on the Tel Aviv Stock Exchange (TASE: KDST). About iTolerance, Inc. iTolerance is an early-stage privately-held regenerative medicine company developing technologies to enable tissue, organoid or cell therapy without requiring life-long immunosuppression. Leveraging its proprietary biotechnology-derived Streptavidin-FasL fusion protein/biotin-PEG microgel (SA-FasL microgel) platform technology, iTOL-100, iTolerance is advancing a pipeline of programs using both allogenic pancreatic islets and stem cells that have the potential to cure diseases. Utilizing iTOL-100 to induce local immune tolerance, the Company is developing its lead indication as a potential cure for Type 1 Diabetes without the need for life-long immunosuppression. Additionally, the Company is developing iTOL-201 for treating liver failure by utilizing hepatocytes and iTOL-401 as a nanoparticle formulation for large organ transplants without the need for life-long immunosuppression. For more information, please visit itolerance.com. Forward Looking Statement This document may include forward-looking information as defined in the Securities Law, 5728 – 1968. Forward-looking information is uncertain and mostly is not under Kadimastem’s control and the realization or non-realization of forward-looking information will be affected, among other things, by the risk factors characterizing the company's activity, as well as developments in the general environment and external factors affecting the company's activity. The company's results and achievements in the future may differ materially from any presented herein and the company makes no undertaking to update or revise such projection or estimate and does not undertake to update this document. This document does not constitute a proposal to purchase the company's securities or an invitation to receive such offers. Investment in securities in general and in the company in particular bears risks. One should consider that past performance does not necessarily indicate performance in the future. Social Media: LinkedIn, Twitter, Facebook Contact Details Kadimastem Asaf Shiloni CEO s.bazak@kadimastem.com iTolerance Jenene Thomas Chief Executive Officer, JTC Team, LLC +1 833-475-8247 iTolerance@jtcir.com Susan Roberts +1 202-779-0929 sr@roberts-communications.com Company Website https://www.kadimastem.com/

January 22, 2024 07:33 AM Eastern Standard Time

Image
Article thumbnail News Release

Top 4 Spinal Injury Stocks for 2024 (NRX.V, NVRO, SYK, BSX)

CGR Spine

Investors eyeing dynamic opportunities in healthcare should take note of the burgeoning growth anticipated in the spinal cord injury market. Projections for robust advancements, driven by enhanced diagnosis and increased global healthcare spending, signal a lucrative trajectory from 2023 to 2032, with a significantly positive CAGR, according to Delveinsights. With the spinal cord injury market showing promising growth, let's explore key stocks that could offer potential returns in the evolving healthcare landscape. NurExone Biologic Inc. (TSXV: NRX) (FSE: J90) is positioned as a pioneering force in biopharmaceuticals, with a primary focus on advancing the field of biologically-guided exosome therapy for traumatic spinal cord injuries. Founded on innovative technology, NurExone's flagship product, ExoPTEN, stands out as a potential game-changer. Administered intranasally, ExoPTEN represents a minimally invasive ExoTherapy designed to induce neuron regeneration and rewiring in traumatically damaged spinal cords. The company holds exclusive worldwide licenses from the Technion and Tel Aviv University, signifying its leadership in translating groundbreaking concepts into actionable solutions. Key milestones in NurExone's journey include a notable Pre-Investigational New Drug (Pre-IND) meeting with the U.S. Food and Drug Administration (FDA). This crucial interaction, held on August 29, 2023, provided clear guidance for the manufacturing, preclinical, and clinical development plans of ExoPTEN. The FDA's endorsement of NurExone's proposed ExoPTEN release testing strategy and toxicity study strategy sets the stage for submitting an Investigational New Drug (IND) application by Q4 2024, with Phase 1/2 human clinical studies anticipated to commence in 2025. In tandem with its commitment to acute spinal cord injury treatments, NurExone secured a $1 million New Israeli Shekels grant from the Israel Innovation Authority. This grant fosters collaboration with Inteligex Inc. to develop an innovative hybrid therapy targeting chronic spinal cord injuries. The collaboration, approved by the Israel-Canada bilateral Eureka program, broadens NurExone's potential market focus. The FDA's grant of Orphan-Drug Designation (ODD) for ExoPTEN therapy on October 30, 2023, marks a pivotal milestone. This designation recognizes the therapy's potential impact on acute spinal cord injuries, offering NurExone significant benefits such as market exclusivity, financial incentives, and regulatory support. The ODD status streamlines the company's go-to-market strategy, signaling a promising path for ExoPTEN. NurExone's commitment to continuous innovation is evident in its laboratory tests unveiled on November 29, 2023. These tests showcased two proprietary small inhibiting RNA sequences targeting the Peri-Neural Network (PNN) complex, representing a significant advancement in spinal cord injury treatment. The potential for two new products in the company's portfolio underscores NurExone's dedication to diversifying its molecular arsenal. The company's financial vitality received a boost with the closure of a non-brokered private placement on January 5, 2024. Raising CAD$1,985,758.04, this investment reflects strong investor confidence in NurExone's technology and direction. The proceeds are earmarked for advancing development activities, expanding the intellectual property portfolio, and supporting overall corporate objectives. More recently, on January 17, 2024, NurExone's collaborative agreement with Inteligex Inc. was officially underway. This collaboration aims to combine Inteligex's expertise in cell-based therapies with NurExone's innovative exosome platform, focusing on developing therapies for chronic spinal cord injuries. Additionally, NurExone has entered into an agreement with bullVestor Medien GmbH to enhance awareness of its products in German-speaking countries. NurExone Biologic Inc. is at the forefront of biologically-guided exosome therapy, supported by a number of milestones and technological advancements. The journey from FDA interactions to collaborative partnerships and financial investments paints a comprehensive picture of NurExone's trajectory, positioning the company as a leader in reshaping the landscape of regenerative therapies for spinal cord injuries. Nevro Corporation (NYSE: NVRO), headquartered in Redwood City, California, stands at the forefront of the medical device industry, specializing in transformative solutions for chronic pain treatment. Focused on their mission to alleviate debilitating pain, Nevro developed the groundbreaking 10 kHz Therapy—an evidence-based, non-pharmacologic innovation that has positively impacted over 100,000 patients worldwide. One notable achievement is the publication of 24-month data from the SENZA Nonsurgical Refractory Back Pain (NSRBP) trial in the Journal of Neurosurgery: Spine. This trial demonstrated the profound benefits of Nevro's high-frequency spinal cord stimulation (SCS) system in managing chronic back pain. Patients experienced significant pain relief, improved function, and enhanced quality of life, with a noteworthy reduction in opioid usage. Moreover, Nevro's strategic acquisition of Vyrsa Technologies expands its portfolio to address chronic sacroiliac joint pain—an essential move in a market valued at over $2 billion and expected to witness double-digit growth. This acquisition positions Nevro to offer tailored therapies, driving long-term shareholder value and contributing to growth projections in 2024. The company's financial performance, highlighted in the fourth-quarter 2023 results, exceeded expectations, showcasing consistent growth and a focus on key pillars: commercial execution, market penetration, and profit progress. Despite a restructuring initiative, Nevro remains committed to innovation, as evidenced by its partnership with Carelon Healthcare to broaden spinal cord stimulation coverage for painful diabetic neuropathy. As Nevro continues to pioneer advancements in chronic pain treatment, its comprehensive solutions and strategic initiatives position it as a key player in the evolving landscape of medical device innovation. Stryker Corporation (NYSE: SYK), a trailblazer in the medical technology domain, recently achieved a historic milestone, surpassing $20 billion in annual sales for the first time in December 2023. This achievement underscores Stryker's global impact on over 130 million patients annually and solidifies its position as a major leader in the medical device industry. Specializing in MedSurg, Neurotechnology, Orthopaedics, and Spine, Stryker stands out for its commitment to innovation and improving healthcare outcomes. In the realm of spine-related technology, the company's Spine division has demonstrated notable advancements, showcasing a dedication to state-of-the-art solutions for surgeons and patients alike. Robbie Robinson, President of the Spine division, emphasized the company's exciting year with multiple product launches, highlighting the continued growth of the Spine business. Among these launches, the Q Guidance System with Spine Guidance Software stands out, receiving the prestigious 2022 Best Technology in Spine award for its contributions to surgical spine planning and navigation. Stryker's commitment to excellence is further evident in products like the Monterey AL Interbody System, incorporating Tritanium In-Growth Technology, and the Bone Mill+, designed for enhanced efficiency in bone milling. The OmniCurve curved balloon system adds another dimension to Stryker's offerings, providing surgeons with advanced capabilities and control. As Stryker achieves record-breaking financial success, its continuous innovation in spine-related technology positions the company as a key player with substantial potential in the medical device sector. Stay tuned for more insights into Stryker's financial results during its upcoming Q4 and full-year earnings call on January 30, 2024. Boston Scientific (NYSE: BSX), a global medical technology leader, has been at the forefront of transforming lives through innovative medical solutions for over 40 years. With a commitment to advancing science and addressing unmet patient needs, the company provides high-performance solutions that enhance healthcare outcomes. In a significant move, Boston Scientific recently completed the acquisition of Relievant Medsystems Inc., marking a milestone in its chronic pain portfolio. Relievant is renowned for its Intracept Intraosseous Nerve Ablation System, the only FDA-cleared therapy for vertebrogenic pain, a form of chronic low back pain. This acquisition strengthens Boston Scientific's position in advanced interventional chronic pain treatments, offering physicians a comprehensive selection of evidence-based options. The Intracept system utilizes basivertebral nerve ablation therapy and has garnered national coverage from major insurers like Anthem Blue Cross Blue Shield and Humana. These coverage expansions, along with existing agreements with Cigna Healthcare and local Medicare plans, significantly increase access to intracept treatments for over 150 million lives. Jim Cassidy, President of Neuromodulation at Boston Scientific, expressed enthusiasm about the revolutionary therapy's potential to help more people suffering from chronic pain. The acquisition, involving an $850 million upfront cash payment and additional contingent payments based on sales performance, is poised to enhance Boston Scientific's capabilities in addressing multiple pain targets. This strategic move reflects Boston Scientific's commitment to offering physicians and patients a diverse range of evidence-based treatment options, further solidifying its position as a leader in the evolving landscape of chronic pain solutions. Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, or assumptions of future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. Capital Gains Report (CGR), owned by RazorPitch Inc., is responsible for the production and distribution of this content. CGR is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. CGR has been retained by Awareness Consulting to produce and distribute this content related to NRX. As part of that content, readers, subscribers, and webs are expected to read the full disclaimers and financial disclosure statement that can be found on our website capitalgainsreport.com All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. CGR is not a fiduciary by virtue of any persons use of or access to this content. Contact Details CapitalGainsReport Mark McKelvie +1 585-748-6862 markrmckelvie@gmail.com

January 22, 2024 05:00 AM Eastern Standard Time

Article thumbnail News Release

RZ Publish Nooro Foot Massager Reviews: Why It Is Used In The United States?

Spark Metro

Are you tired of living with constant burning and tingling in your feet due to neuropathy? Frustrated with painkillers that merely numb the discomfort without addressing the root cause? If so, you're not alone. Many have experienced the struggle of seeking relief from neuropathic pain, only to find temporary solutions. However, you are lucky to have come across this review because it is a comprehensive report about a breakthrough device popularly known as Nooro Foot Massager that goes beyond masking the symptoms, offering a chance to reverse nerve damage and regain a life free from persistent foot pain. In a world where traditional remedies may involve uncomfortable movements, Dr. Jeremy Campbell, in collaboration with the innovative med tech startup Nooro, introduces Nooro Foot Massager as a simple at-home solution for foot pain powered by Neuromuscular Electrical Stimulation (NMES) technology. This is where the story takes a turn towards hope and healing. Are you ready to break free from neuropathic pain and experience the relief you've been longing for? The Nooro Foot Massager might just be your key to a new lease on life. What Is Nooro Foot Massager? Nooro Foot Massager is a revolutionary at-home solution developed through the collaboration of Dr. Jeremy Campbell and the innovative med tech startup, Nooro. Designed to address neuropathic foot pain, Nooro Foot Massager device employs NeuroMuscular Electrical Stimulation (NMES) technology to offer relief in the comfort of your home. Specifically named the Nooro Foot Massager, this device stands out by delivering a unique combination of targeted electric impulses deep into the tissues of your feet and legs. The primary goal? To kickstart blood circulation, a crucial factor in providing the oxygen necessary for nerve recovery. By enhancing blood flow to your feet, the Nooro Foot Massager becomes a catalyst for nerve repair and healing. This breakthrough approach holds the promise of reducing the burning pain, tingling, and numbness associated with neuropathy. The ultimate result? A chance to reclaim the activities you love, free from the constant foot pain and swelling that may have confined you. This user-friendly device opens doors to a life where neuropathic pain no longer dictates your daily experiences, offering a pathway to comfort and mobility. In essence, the Nooro Foot Massager is more than just a device – it's a transformative tool designed to empower you on your journey to relief from neuropathic foot pain. CLICK HERE NOW TO GET THE NOORO FOOT MASSAGER DIRECTLY FROM THE OFFICIAL WEBSITE Features (Nooro Foot Massager Reviews USA) EMS Technology: The Nooro Foot Massager employs advanced NeuroMuscular Electrical Stimulation (EMS) technology. This technology facilitates the penetration of steady electric impulses deep into the tissues of the feet and legs, aiming to relieve muscle tension, increase blood circulation, and strengthen weakened muscles. Cordless Convenience: The Nooro EMS Foot Massager offers a cordless design, eliminating the hassle of dealing with tangled cords during use. Charging is simple using the provided electricity plug and cable, ensuring a convenient and clutter-free experience. Optional Preparatory Step: While optional, the recommendation to wash your feet and remove excess skin before using the massager adds a thoughtful touch. This preparatory step enhances the overall effectiveness of the massage treatment, promoting a more thorough and satisfying experience. Versatile Massage Modes: The device features a variety of different modes, providing users with options to cater to their specific needs. Whether you're looking to relax after a long day or target particular muscle groups causing discomfort, the Nooro Foot Massager's versatility ensures a customized and enjoyable experience. Adjustable Intensity Levels: Tailoring the massage experience to individual preferences, the massager offers a mind-bending number of speed settings. This wide range allows users to find the perfect intensity level, ensuring that the massage is both effective and comfortable for various muscle groups. User-Friendly Operation: The massager's simplicity is a standout feature. With easy-to-follow steps—place your feet on the foot pad, select the mode, and adjust intensity—you can initiate the massage effortlessly. The user-friendly design ensures that anyone can enjoy the benefits without a steep learning curve. Effective Neuropathy Relief: The Nooro Foot Massager is specifically designed to address neuropathic foot pain. By enhancing blood circulation, relieving muscle tension, and providing a targeted massage experience, the device aims to alleviate burning pain, tingling, and numbness. Users can experience liberation from the challenges of neuropathy, promoting overall foot health and well-being. Benefits Of Nooro Foot Massager Pain Alleviation: A primary benefit of the Nooro Foot Massager is its ability to ease neuropathic foot pain. By employing advanced EMS technology, the massager delivers targeted electric impulses to alleviate burning sensations and discomfort associated with neuropathy. Users may experience significant relief from persistent foot pain. Tingling Relief: This innovative EMS massager targets nerve-related tingling sensations by enhancing blood circulation. Through its unique combination of electric impulses, the Nooro Foot Massager aims to improve oxygen supply to peripheral nerves, reducing tingling and promoting a sense of comfort. Numbness Reduction: For individuals experiencing numbness due to neuropathy, the Nooro Foot Massager offers hope. By increasing blood flow to the feet and facilitating nerve repair, the device strives to reduce numbness, allowing users to regain sensation in their extremities. Improved Blood Circulation: A core benefit lies in the massager's ability to enhance blood circulation. The EMS technology stimulates blood flow to the feet and legs, ensuring a continuous supply of oxygen to nerve cells. Improved circulation contributes not only to pain relief but also to overall foot health. Muscle Strengthening: Beyond addressing neuropathic pain, the Nooro Foot Massager helps strengthen weakened muscles. The electric impulses penetrate deep into the tissues, promoting muscle stimulation. This additional benefit contributes to overall foot strength and may aid in preventing future discomfort. Convenience and Comfort: The cordless design, along with the straightforward operational steps, adds a layer of convenience to the user experience. The Nooro Foot Massager provides a hassle-free solution for those seeking comfort and relief. Users can enjoy the benefits of a personalized massage without the inconvenience of cords or complicated setup. How Does Nooro Foot Massager Work? (Nooro Foot Massager Reviews) The Nooro EMS Foot Massager operates on advanced EMS (Electrical Muscle Stimulation) technology, offering a multi-faceted approach to relieving discomfort. True to its name, using this device is as simple as placing your feet on it and letting it work its magic. Specifically, Nooro EMS Foot Massager works by increasing blood flow to your feet, the massager facilitates the delivery of much-needed oxygen to nerve cells. This groundbreaking approach opens the door to nerve repair and healing, reducing burning pain, tingling, and numbness. But here's the beauty of it – as long as your nerves are alive, there's hope for reversal. The National Institute of Health emphasizes the regenerative capacity of peripheral nerves when the underlying nerve cell remains intact. The Nooro Foot Massager becomes a tool for revitalization, offering relief and a chance to reclaim a life without constant foot pain. This innovative massager employs steady electric impulses that penetrate deep into your feet and legs, effectively targeting muscle tension. The result? Relaxation of tense muscles, which is essential for alleviating discomfort associated with neuropathic foot pain. What sets the Nooro Foot Massager apart is its versatility. With a variety of modes and an impressive array of speed settings, the device allows you to tailor your experience to address specific muscle groups. This flexibility ensures that you can find a satisfying combination, catering to the unique needs of whatever muscle group is causing you distress. In essence, the Nooro Foot Massager is designed to be user-friendly and customizable. Its cutting-edge EMS technology aims to enhance blood circulation, relieve muscle tension, and strengthen weakened muscles, all while providing a hassle-free experience. So, whether you're looking to unwind after a long day or target specific muscle groups causing discomfort, this device offers a personalized solution to meet your needs. Who Needs Nooro Foot Massager? Foot Pain and Discomfort: If your feet hurt or feel uncomfortable, the Nooro Foot Massager can give you relief and make you feel better. Plantar Fasciitis: If you have plantar fasciitis (pain in the bottom of your feet), using the massager can help ease the pain and make your feet more comfortable. Athletes and Runners: Athletes and runners can use the massager to relax their muscles and recover faster after exercising. Diabetes: If you have diabetes and your feet need extra care, the Nooro Foot Massager can be part of your routine to keep your feet comfortable. Swelling: If your feet are swollen, especially during pregnancy or due to certain health issues, the Nooro Foot Massager can help reduce the swelling. General Well-being: If you just want to feel better overall and more relaxed, using the Nooro Foot Massager can contribute to your well-being. CLICK HERE NOW TO GET THE NOORO FOOT MASSAGER DIRECTLY FROM THE OFFICIAL WEBSITE AT A MASSIVE DISCOUNT Does Nooro EMS Foot Massager Really Work? Absolutely, the Nooro EMS Foot Massager has garnered positive reviews from satisfied customers, attesting to its effectiveness. Users express genuine satisfaction with the relief it provides, particularly in addressing knee-related concerns. Many have reported that it contributes to a positive sensation in their knees, offering comfort and support, especially before bedtime. Customers dealing with foot pains have found solace in the Nooro Foot Massager. The device seems to provide tangible relief, soothing discomfort associated with foot pains. The positive feedback highlights the impact of the massager in helping alleviate foot-related issues, making it a promising solution for those seeking relief from foot pain. One user shared their experience, noting the immediate positive effects after just one use. This firsthand account emphasizes the rapid and noticeable benefits users can expect, further reinforcing the idea that the Nooro EMS Foot Massager indeed works to bring comfort and relief. In essence, the testimonials from customers reflect a consensus that the Nooro EMS Foot Massager is not just a device but a reliable solution that genuinely addresses pain and discomfort, particularly in the knees. The positive feedback from users reinforces the notion that the Nooro Foot Massager is effective in delivering the relief it promises. How To Use Nooro Foot Massager? Using the Nooro EMS Foot Massager is delightfully straightforward, making it a hassle-free addition to your routine. First and foremost, you'll appreciate the absence of annoying cords – charging is a breeze with the included electricity plug and cable that come with your order. Once charged, the process is as simple as 1-2-3. For an optimal experience, the second step is optional but recommended – give your feet a quick wash and remove any excess skin. This preparatory step significantly enhances the effectiveness of the massage treatment. Now, you're ready to indulge in the soothing benefits of the Nooro Foot Massager. Just place your feet on the foot pad, select your preferred mode, and adjust the intensity level of the massage to your liking. It's a customizable experience tailored to meet your unique needs. From there, all that's left to do is sit back comfortably and let the massager work its magic. As it eases pain, relieves tingling, and liberates you from the challenges of neuropathy, you'll find a newfound sense of comfort and relief. The Nooro Foot Massager brings simplicity and effectiveness together, making it a user-friendly solution for those seeking relief from neuropathic foot pain. Price Of Nooro Foot Massager And Where To Buy Nooro Foot Massager can be gotten directly from the manufacturer’s official website at the following prices: Single Unit: Buy one Nooro Foot Massager for $99.95. Two Units: Buy two Nooro Foot Massagers for $94.95 each. Total cost: $189.90. Three Units: Buy three Nooro Foot Massagers for $89.95 each. Total cost: $269.85. Four Units: Buy four Nooro Foot Massagers for $87.95 each. Total cost: $351.80. Six Units: Buy six Nooro Foot Massagers for $84.95 each. CLICK HERE NOW TO GET THE NOORO FOOT MASSAGER DIRECTLY FROM THE OFFICIAL WEBSITE Nooro Foot Massager Reviews Consumer Reports And Customer Complaints The Nooro EMS Foot Massager has received overwhelmingly positive consumer reports, with an impressive 4.8-star rating and a noteworthy achievement of zero customer complaints. Thousands of individuals have experienced successful outcomes in reversing neuropathy with this device, highlighting its efficacy and customer satisfaction. Harry Keegan - “Superb relaxation, it's not bulky, so you can take it anywhere, cheaper than other massagers, does what it says. You'll love the "cupping mode". Many intensity options (up to 19). It's a great product with fast shipping! My wife loves it…” Debra Peyton - “Should have bought Nooro Foot Massager earlier, exactly what I needed for my neuropathy-pained-feet. Honestly, I can walk and move with just minimal pain. I've only used it for like 2 days and I have felt better than I have in the past 2 years!!!” Clara Milton - “I absolutely love my Nooro EMS Foot Massager massager, had to get one for my daughter today since she wont stop using mine!” Final Verdict On Nooro EMS Foot Massager Reviews The overwhelming positive reviews and testimonials for the Nooro Foot Massager paint a compelling picture of its effectiveness and customer satisfaction. With a remarkable 4.8-star rating and zero customer complaints, it stands out as a reliable solution for those seeking relief from neuropathic foot pain. Customers like Harry Keegan commend the massager for its superb relaxation, portability, affordability, and diverse intensity options. The mention of the "cupping mode" adds to the device's appeal. Debra Peyton's experience reinforces the quick and tangible relief the Nooro Foot Massager provides, enabling her to walk with minimal pain after just two days of use. Clara Milton's enthusiasm and the decision to purchase an additional massager for her daughter further underscore the positive impact and effectiveness of the device. In the final verdict, the Nooro Foot Massager emerges as a standout product, praised for its user-friendly design, versatility, and ability to address neuropathy-induced foot pain. The absence of customer complaints reinforces its credibility, making it a promising choice for those in search of a reliable and effective solution to neuropathic pain. CLICK HERE NOW TO GET THE NOORO FOOT MASSAGER DIRECTLY FROM THE OFFICIAL WEBSITE Disclaimer: Please understand that any advice or guidelines revealed here are not even remotely substitutes for sound medical or financial advice from a licensed healthcare provider or certified financial advisor. Make sure to consult with a professional physician or financial consultant before making any purchasing decision if you use medications or have concerns following the review details shared above. Individual results may vary. These products are not intended to diagnose, treat, cure or prevent any disease and do not provide any kind of get-rich money scheme. Reviewer is not responsible for pricing inaccuracies. Check product sales page for final prices. Contact Details Review Zenith Alex +1 302-597-6768 Apexreviews154@gmail.com Company Website https://reviewzenith.com/

January 22, 2024 04:37 AM Eastern Standard Time

Image
Article thumbnail News Release

RZ Publish Nooro Foot Massager Reviews: Why Is It Used In The United States?

Spark Metro

Are you tired of living with constant burning and tingling in your feet due to neuropathy? Frustrated with painkillers that merely numb the discomfort without addressing the root cause? If so, you're not alone. Many have experienced the struggle of seeking relief from neuropathic pain, only to find temporary solutions. However, you are lucky to have come across this review because it is a comprehensive report about a breakthrough device popularly known as Nooro Foot Massager that goes beyond masking the symptoms, offering a chance to reverse nerve damage and regain a life free from persistent foot pain. In a world where traditional remedies may involve uncomfortable movements, Dr. Jeremy Campbell, in collaboration with the innovative med tech startup Nooro, introduces Nooro Foot Massager as a simple at-home solution for foot pain powered by Neuromuscular Electrical Stimulation (NMES) technology. This is where the story takes a turn towards hope and healing. Are you ready to break free from neuropathic pain and experience the relief you've been longing for? The Nooro Foot Massager might just be your key to a new lease on life. What Is Nooro Foot Massager? Nooro Foot Massager is a revolutionary at-home solution developed through the collaboration of Dr. Jeremy Campbell and the innovative med tech startup, Nooro. Designed to address neuropathic foot pain, Nooro Foot Massager device employs NeuroMuscular Electrical Stimulation (NMES) technology to offer relief in the comfort of your home. Specifically named the Nooro Foot Massager, this device stands out by delivering a unique combination of targeted electric impulses deep into the tissues of your feet and legs. The primary goal? To kickstart blood circulation, a crucial factor in providing the oxygen necessary for nerve recovery. By enhancing blood flow to your feet, the Nooro Foot Massager becomes a catalyst for nerve repair and healing. This breakthrough approach holds the promise of reducing the burning pain, tingling, and numbness associated with neuropathy. The ultimate result? A chance to reclaim the activities you love, free from the constant foot pain and swelling that may have confined you. This user-friendly device opens doors to a life where neuropathic pain no longer dictates your daily experiences, offering a pathway to comfort and mobility. In essence, the Nooro Foot Massager is more than just a device – it's a transformative tool designed to empower you on your journey to relief from neuropathic foot pain. CLICK HERE NOW TO GET THE NOORO FOOT MASSAGER DIRECTLY FROM THE OFFICIAL WEBSITE Features (Nooro Foot Massager Reviews USA) EMS Technology: The Nooro Foot Massager employs advanced NeuroMuscular Electrical Stimulation (EMS) technology. This technology facilitates the penetration of steady electric impulses deep into the tissues of the feet and legs, aiming to relieve muscle tension, increase blood circulation, and strengthen weakened muscles. Cordless Convenience: The Nooro EMS Foot Massager offers a cordless design, eliminating the hassle of dealing with tangled cords during use. Charging is simple using the provided electricity plug and cable, ensuring a convenient and clutter-free experience. Optional Preparatory Step: While optional, the recommendation to wash your feet and remove excess skin before using the massager adds a thoughtful touch. This preparatory step enhances the overall effectiveness of the massage treatment, promoting a more thorough and satisfying experience. Versatile Massage Modes: The device features a variety of different modes, providing users with options to cater to their specific needs. Whether you're looking to relax after a long day or target particular muscle groups causing discomfort, the Nooro Foot Massager's versatility ensures a customized and enjoyable experience. Adjustable Intensity Levels: Tailoring the massage experience to individual preferences, the massager offers a mind-bending number of speed settings. This wide range allows users to find the perfect intensity level, ensuring that the massage is both effective and comfortable for various muscle groups. User-Friendly Operation: The massager's simplicity is a standout feature. With easy-to-follow steps—place your feet on the foot pad, select the mode, and adjust intensity—you can initiate the massage effortlessly. The user-friendly design ensures that anyone can enjoy the benefits without a steep learning curve. Effective Neuropathy Relief: The Nooro Foot Massager is specifically designed to address neuropathic foot pain. By enhancing blood circulation, relieving muscle tension, and providing a targeted massage experience, the device aims to alleviate burning pain, tingling, and numbness. Users can experience liberation from the challenges of neuropathy, promoting overall foot health and well-being. Benefits Of Nooro Foot Massager Pain Alleviation: A primary benefit of the Nooro Foot Massager is its ability to ease neuropathic foot pain. By employing advanced EMS technology, the massager delivers targeted electric impulses to alleviate burning sensations and discomfort associated with neuropathy. Users may experience significant relief from persistent foot pain. Tingling Relief: This innovative EMS massager targets nerve-related tingling sensations by enhancing blood circulation. Through its unique combination of electric impulses, the Nooro Foot Massager aims to improve oxygen supply to peripheral nerves, reducing tingling and promoting a sense of comfort. Numbness Reduction: For individuals experiencing numbness due to neuropathy, the Nooro Foot Massager offers hope. By increasing blood flow to the feet and facilitating nerve repair, the device strives to reduce numbness, allowing users to regain sensation in their extremities. Improved Blood Circulation: A core benefit lies in the massager's ability to enhance blood circulation. The EMS technology stimulates blood flow to the feet and legs, ensuring a continuous supply of oxygen to nerve cells. Improved circulation contributes not only to pain relief but also to overall foot health. Muscle Strengthening: Beyond addressing neuropathic pain, the Nooro Foot Massager helps strengthen weakened muscles. The electric impulses penetrate deep into the tissues, promoting muscle stimulation. This additional benefit contributes to overall foot strength and may aid in preventing future discomfort. Convenience and Comfort: The cordless design, along with the straightforward operational steps, adds a layer of convenience to the user experience. The Nooro Foot Massager provides a hassle-free solution for those seeking comfort and relief. Users can enjoy the benefits of a personalized massage without the inconvenience of cords or complicated setup. How Does Nooro Foot Massager Work? (Nooro Foot Massager Reviews) The Nooro EMS Foot Massager operates on advanced EMS (Electrical Muscle Stimulation) technology, offering a multi-faceted approach to relieving discomfort. True to its name, using this device is as simple as placing your feet on it and letting it work its magic. Specifically, Nooro EMS Foot Massager works by increasing blood flow to your feet, the massager facilitates the delivery of much-needed oxygen to nerve cells. This groundbreaking approach opens the door to nerve repair and healing, reducing burning pain, tingling, and numbness. But here's the beauty of it – as long as your nerves are alive, there's hope for reversal. The National Institute of Health emphasizes the regenerative capacity of peripheral nerves when the underlying nerve cell remains intact. The Nooro Foot Massager becomes a tool for revitalization, offering relief and a chance to reclaim a life without constant foot pain. This innovative massager employs steady electric impulses that penetrate deep into your feet and legs, effectively targeting muscle tension. The result? Relaxation of tense muscles, which is essential for alleviating discomfort associated with neuropathic foot pain. What sets the Nooro Foot Massager apart is its versatility. With a variety of modes and an impressive array of speed settings, the device allows you to tailor your experience to address specific muscle groups. This flexibility ensures that you can find a satisfying combination, catering to the unique needs of whatever muscle group is causing you distress. In essence, the Nooro Foot Massager is designed to be user-friendly and customizable. Its cutting-edge EMS technology aims to enhance blood circulation, relieve muscle tension, and strengthen weakened muscles, all while providing a hassle-free experience. So, whether you're looking to unwind after a long day or target specific muscle groups causing discomfort, this device offers a personalized solution to meet your needs. Who Needs Nooro Foot Massager? Foot Pain and Discomfort: If your feet hurt or feel uncomfortable, the Nooro Foot Massager can give you relief and make you feel better. Plantar Fasciitis: If you have plantar fasciitis (pain in the bottom of your feet), using the massager can help ease the pain and make your feet more comfortable. Athletes and Runners: Athletes and runners can use the massager to relax their muscles and recover faster after exercising. Diabetes: If you have diabetes and your feet need extra care, the Nooro Foot Massager can be part of your routine to keep your feet comfortable. Swelling: If your feet are swollen, especially during pregnancy or due to certain health issues, the Nooro Foot Massager can help reduce the swelling. General Well-being: If you just want to feel better overall and more relaxed, using the Nooro Foot Massager can contribute to your well-being. CLICK HERE NOW TO GET THE NOORO FOOT MASSAGER DIRECTLY FROM THE OFFICIAL WEBSITE AT A MASSIVE DISCOUNT Does Nooro EMS Foot Massager Really Work? Absolutely, the Nooro EMS Foot Massager has garnered positive reviews from satisfied customers, attesting to its effectiveness. Users express genuine satisfaction with the relief it provides, particularly in addressing knee-related concerns. Many have reported that it contributes to a positive sensation in their knees, offering comfort and support, especially before bedtime. Customers dealing with foot pains have found solace in the Nooro Foot Massager. The device seems to provide tangible relief, soothing discomfort associated with foot pains. The positive feedback highlights the impact of the massager in helping alleviate foot-related issues, making it a promising solution for those seeking relief from foot pain. One user shared their experience, noting the immediate positive effects after just one use. This firsthand account emphasizes the rapid and noticeable benefits users can expect, further reinforcing the idea that the Nooro EMS Foot Massager indeed works to bring comfort and relief. In essence, the testimonials from customers reflect a consensus that the Nooro EMS Foot Massager is not just a device but a reliable solution that genuinely addresses pain and discomfort, particularly in the knees. The positive feedback from users reinforces the notion that the Nooro Foot Massager is effective in delivering the relief it promises. How To Use Nooro Foot Massager? Using the Nooro EMS Foot Massager is delightfully straightforward, making it a hassle-free addition to your routine. First and foremost, you'll appreciate the absence of annoying cords – charging is a breeze with the included electricity plug and cable that come with your order. Once charged, the process is as simple as 1-2-3. For an optimal experience, the second step is optional but recommended – give your feet a quick wash and remove any excess skin. This preparatory step significantly enhances the effectiveness of the massage treatment. Now, you're ready to indulge in the soothing benefits of the Nooro Foot Massager. Just place your feet on the foot pad, select your preferred mode, and adjust the intensity level of the massage to your liking. It's a customizable experience tailored to meet your unique needs. From there, all that's left to do is sit back comfortably and let the massager work its magic. As it eases pain, relieves tingling, and liberates you from the challenges of neuropathy, you'll find a newfound sense of comfort and relief. The Nooro Foot Massager brings simplicity and effectiveness together, making it a user-friendly solution for those seeking relief from neuropathic foot pain. Price Of Nooro Foot Massager And Where To Buy Nooro Foot Massager can be gotten directly from the manufacturer’s official website at the following prices: Single Unit: Buy one Nooro Foot Massager for $99.95. Two Units: Buy two Nooro Foot Massagers for $94.95 each. Total cost: $189.90. Three Units: Buy three Nooro Foot Massagers for $89.95 each. Total cost: $269.85. Four Units: Buy four Nooro Foot Massagers for $87.95 each. Total cost: $351.80. Six Units: Buy six Nooro Foot Massagers for $84.95 each. CLICK HERE NOW TO GET THE NOORO FOOT MASSAGER DIRECTLY FROM THE OFFICIAL WEBSITE Nooro Foot Massager Reviews Consumer Reports And Customer Complaints The Nooro EMS Foot Massager has received overwhelmingly positive consumer reports, with an impressive 4.8-star rating and a noteworthy achievement of zero customer complaints. Thousands of individuals have experienced successful outcomes in reversing neuropathy with this device, highlighting its efficacy and customer satisfaction. Harry Keegan - “Superb relaxation, it's not bulky, so you can take it anywhere, cheaper than other massagers, does what it says. You'll love the "cupping mode". Many intensity options (up to 19). It's a great product with fast shipping! My wife loves it…” Debra Peyton - “Should have bought Nooro Foot Massager earlier, exactly what I needed for my neuropathy-pained-feet. Honestly, I can walk and move with just minimal pain. I've only used it for like 2 days and I have felt better than I have in the past 2 years!!!” Clara Milton - “I absolutely love my Nooro EMS Foot Massager massager, had to get one for my daughter today since she wont stop using mine!” Final Verdict On Nooro EMS Foot Massager Reviews The overwhelming positive reviews and testimonials for the Nooro Foot Massager paint a compelling picture of its effectiveness and customer satisfaction. With a remarkable 4.8-star rating and zero customer complaints, it stands out as a reliable solution for those seeking relief from neuropathic foot pain. Customers like Harry Keegan commend the massager for its superb relaxation, portability, affordability, and diverse intensity options. The mention of the "cupping mode" adds to the device's appeal. Debra Peyton's experience reinforces the quick and tangible relief the Nooro Foot Massager provides, enabling her to walk with minimal pain after just two days of use. Clara Milton's enthusiasm and the decision to purchase an additional massager for her daughter further underscore the positive impact and effectiveness of the device. In the final verdict, the Nooro Foot Massager emerges as a standout product, praised for its user-friendly design, versatility, and ability to address neuropathy-induced foot pain. The absence of customer complaints reinforces its credibility, making it a promising choice for those in search of a reliable and effective solution to neuropathic pain. CLICK HERE NOW TO GET THE NOORO FOOT MASSAGER DIRECTLY FROM THE OFFICIAL WEBSITE Disclaimer: Please understand that any advice or guidelines revealed here are not even remotely substitutes for sound medical or financial advice from a licensed healthcare provider or certified financial advisor. Make sure to consult with a professional physician or financial consultant before making any purchasing decision if you use medications or have concerns following the review details shared above. Individual results may vary. These products are not intended to diagnose, treat, cure or prevent any disease and do not provide any kind of get-rich money scheme. Reviewer is not responsible for pricing inaccuracies. Check product sales page for final prices. Contact Details Review Zenith Alex +1 302-597-6768 Apexreviews154@gmail.com Company Website https://reviewzenith.com

January 22, 2024 04:12 AM Eastern Standard Time

Image
Article thumbnail News Release

New Device is Helping Patients Make Strides with their Mobility

YourUpdateTV

For those living with mobility impairments, wheelchairs, walkers and canes are a necessity for everyday life. While technological advancement has completely transformed almost every sector over the last century, innovation in mobility aids has largely remained the same. Recently, Founder and CEO of CIONIC, Jeremiah Robison, as well as Patty Glatfelter, a multiple sclerosis patient whose life has been transformed thanks to the Cionic Neural Sleeve, conducted a satellite media tour to share insights on the Cionic Neural Sleeve that's earned recognition as one of Time's Best Inventions of 2023. A video accompanying this announcement is available at: https://youtu.be/ZyJLaAuRp2c People living with mobility impairments are asking for, and deserve, better tools, harnessing the power of modern technology. Motivated by his daughter Sofia’s mobility challenges from cerebral palsy, tech innovator Jeremiah Robison founded CIONIC to harness the technological advances in continuous diagnostics and machine learning to help the mobility impaired not only regain mobility in the moment, but potentially improve it by strengthening and retraining the body over time. CIONIC is a neurotech company on a mission to superpower the human body to reach its fullest potential. CIONIC’s vision is a world beyond disability and limitations, enabled by personalized healthcare technology. The company’s premier product, the FDA-cleared Cionic Neural Sleeve, is changing the lives of people with upper motor neuron conditions (multiple sclerosis, stroke, cerebral palsy, spinal cord injury and more) drastically increasing their ability to walk, move and balance. Voted one of Time’s Best Inventions of 2023, The Cionic Neural Sleeve analyzes, predicts, and augments muscles in the leg to improve walking, updating with each step the wearer takes. To learn more visit cionic.com Jeremiah Robison Bio Jeremiah Robison is the Founder and CEO of CIONIC, an innovative company that builds lightweight and durable bionic clothing driven by powerful algorithms that adapt in real-time to each individual's mobility needs. He started the company in 2018 after his daughter was diagnosed with cerebral palsy and he was frustrated at the lack of effective technology available to help improve her mobility. Four years later, CIONIC introduced the breakthrough, FDA-cleared Cionic Neural Sleeve, the first product to combine sensing, analysis and augmentation into a wearable garment. Prior to CIONIC, Jeremiah spent twenty years at the intersection of data, algorithms, and the human body, driving innovation in sensing and machine learning at Apple, Openwave Systems, Slide, and Jawbone. Jeremiah has a BS and MS in Computer Science from Stanford University. About Patty Glatfelter Patty Glatfelter, 69, a Florissant, CO resident who has had multiple sclerosis (MS) for 37 years, has been using the Cionic Neural Sleeve for almost a year now. Patty, a former physical therapist, retired back in 2008 because of her limitations to provide care due to her MS. Before the Cionic Neural Sleeve, she couldn’t walk 50 feet and experienced periods of remissions, as well as stages where she relied on a walker, cane, and wheelchair. It was a rollercoaster ride for about eight to ten years. Her doctor even thought that within the first three to five years of her MS diagnosis, she would be in a wheelchair permanently. Her quality of life was limited. She had to cook sitting down and could stand for about 15 minutes before needing a break. She couldn’t take socks out of the dryer or go for walks outside of her house on the mountains alone. Ever since she started using the Cionic Neural Sleeve, she instantly saw a difference. She notes that she was “astounded by how well [I] was walking.” The Cionic Neural Sleeve has restored her ability to do many everyday things, including taking clothes out of the dryer, going for walks, taking vacations, climbing lighthouses and seeing friends and family. She even notes that she is better now than she was ten years ago. She describes the experience as “a perfect storm in a good way.” Contact Details YourUpdateTV +1 212-736-2727 yourupdatetv@gmail.com

January 19, 2024 12:29 PM Eastern Standard Time

Video
Article thumbnail News Release

Artificial Intelligence: OurCrowd’s 20 Verticals For Investors To Watch

OurCrowd

AI seems to be the world’s fastest-growing investment sector. The rush of interest in ChatGPT and similar generative AI platforms has triggered a global wave of funding for the new technology. “Artificial intelligence may be one of the biggest technological leaps in history. It is poised to unlock new business models, transform industries, reshape people’s jobs, and boost economic productivity,” Goldman Sachs says in a special report. The AI and machine learning market reached $197.5 billion in end-user spending in 2022 according to PitchBook. Generative AI will become a $1.3 trillion market by 2032, rising at a compound annual growth rate of 42%, says Bloomberg Intelligence. Investors need to take a vertical view of the AI revolution. The application of AI to each business vertical will transform our world and shape the economies of the future. AI is poised to affect every industry sector, with an impact comparable to the introduction of computerization and, before that, electricity. “Generative AI has the potential to change the world, but you need to be in it for the long haul,” Gary Munitz, Executive Director at Australia-based Macquarie Capital, told PitchBook at the 2023 OurCrowd Global Investor Summit. “If you understand the real-world use cases, then it’s worth investing in – but if you just think the tech is cool, then it’s not for you. It could be years until we see outcomes, and investors will need to be patient.” OurCrowd’s portfolio includes One AI, a generative AI platform that empowers businesses to rapidly deploy the world’s leading AI capabilities in their own products and services. The use of AI will differ depending on the application. To understand the future of AI as investors and how to deploy capital most effectively, we need to consider each of these verticals and not just the horizontal impact of AI across the board. We are already seeing the successful deployment of AI technology in those sectors where the light-speed analysis of vast amounts of data can help produce rapid, automated solutions that previously would have been impossible to achieve – or at least taken much longer. OurCrowd has more than 80 investments – about 20% of its portfolio – based on AI technology, and the number is growing. These companies are not just using general AI principles and technologies but are developing specific AI techniques applied to specialist areas. Investors specializing in each of those sectors will be better placed to gauge the impact of AI on those industries and the potential of the startups seeking to disrupt them. The next wave of investment in AI will be in companies applying this new core technology to specific industry verticals that are likely to be revolutionized as a result. There will be huge opportunities for investment in these verticalized plays, which are not yet fully appreciated and are still valued at fractions of their potential. Just this week, Google Cloud announced two new AI-powered life sciences solutions to accelerate drug discovery and precision medicine. “These new solutions launching today can transform life sciences organizations by accelerating drug discovery and bringing therapeutics to market faster,” said Shweta Maniar, global director, Life Sciences Strategy and Solutions, Google Cloud. “When patients are waiting for that life-saving treatment in cancer care or that quality-of-life medicine for migraine headaches, this faster time-to-market can have an incredibly positive impact on lives.” OurCrowd’s AI-powered drug discovery company portfolio company CytoReason already has multimillion-dollar contracts with Pfizer (NYSE: PFE) and Sanofi, and it is working with many of the top global pharma companies to develop innovative treatments. Here are 20 AI verticals for investors to watch, with relevant examples from our own portfolio: 1. AI for medical and life sciences CytoReason: AI for drug discovery. Pfizer is a strategic investor, also with a $90 million, multiyear software deal. Working with five of the world’s 10 largest pharma companies, including a multiyear, multimillion-dollar deal with Sanofi. Medaware: AI-powered medication safety monitoring platform identifies preventable medication-related risks, helping to prevent dangerous prescription errors. Diagnostic Robotics: Integrated population health management, triage and medical navigation. Sight Diagnostics: Platform for blood analysis and infectious disease diagnostics based on its AI and computer vision technology. MeMed: Machine learning-based diagnostic solutions for infectious diseases. Scopio Labs: Computational imaging-based digital microscopes and image analysis tools. BrainQ: AI-based wearable devices to treat neurological disorders. AEye Health: Fully autonomous, AI-based diagnostic screening solutions for retinal imaging. 2. AI for mobility Ride Vision: AI-powered Collision Aversion Technology keeps motorcycle riders safer and saves lives. CorrActions: Uses existing in-vehicle sensors to measure driver sobriety, awareness, fatigue and other factors, and intervenes via automated systems to alter the vehicle’s speed, route and performance. Volvo is a strategic investor. Autobrains: Automotive visual intelligence platform with new self-learning approach that mimics human driving perception to provide safer, superior performance at lower cost and energy consumption. Sfara: Transforms smartphones and tablets into a secure mobile safety and analytics platform, saving lives by enabling safety and collision management for global enterprises. 3. AI for banking and financial security ThetaRay: Detects financial fraud in account movements and protects correspondent banking transactions. BioCatch: Detects financial fraud in consumer behavior. OneZero: All-digital bank offering private banking experience. Israel’s fastest-growing lender. 4. AI for agriculture and food CropX: Cloud processing and integration of data from soil sensors and other data sets to optimize water and fertilizer use for farmers. Taranis: AI-driven SaaS platform transforming demand intelligence for the Agri-business value chain. Tevel: Flying Autonomous Robots™ driven by state-of-the-art AI and computer vision algorithms to gently pick fruit. BlueCircle: Cloud-based SaaS platform that gives food and beverage producers unprecedented predictions of yield and crops, quality, timing and unit cost based on weather, water and input supply and other vital information. 5. AI for business Anodot: Monitors all business data in real time, enabling customers to proactively resolve revenue, cost, and customer experience issues before they impact the business. One AI: Cutting-edge language AI platform enabling businesses to seamlessly integrate AI into their products and services. Leo AI: Generative AI platform for engineers turns designs into products in seconds, slashing costs and time-to-market. 6. AI for energy mPrest: AI-powered real-time management of smart energy grids and other utilities to improve efficiency. 7. AI for software coding Tabnine: Generative AI technology to predict and suggest programmers’ next lines of code based on context and syntax. 8. AI for education Sense Education: Grading tests and student evaluations based on unstructured data. 9. AI for video D-ID: Generative AI enables users to transform any picture or video into extraordinary experiences, adding instant translations and other features. 10. AI for elder care Intuition Robotics: AI-based empathetic digital companion for older adults that motivates engagement, connection and independence. 11. AI for materials Materials Zone: Optimizes and organizes materials science R&D and manufacturing, speeding up time to market to reduce cost and increase revenue associated with developing new materials. 12. AI for content monitoring and verification Cyabra: Stamp of credibility and trust of social media actors and conversations, filtering between real, bad, and fake, including generative AI. Hired by Elon Musk to expose Twitter fakes. Spectrum Labs: AI-driven SaaS content moderation platform helps consumer-facing companies recognize and respond to harmful behavior on their platforms. 13. AI for next-gen retail Zippin: Checkout-free shopping for a frictionless customer experience, like Amazon Go, that dramatically improves store profitability and delights customers. 14. AI for physical security SeeTrue: Revolutionizes travel security screening, addressing the challenges of passenger throughput, experience, security and cost. 15. Semiconductors for AI Hailo: One of the world’s top-performing AI processors for edge devices with high performance at low cost and power consumption. NeuReality: Proprietary systems that accelerate the adoption of AI by significantly improving the performance of AI chips, reducing hardware and energy costs. 16. AI for fitness Kemtai: Uses advanced computer vision to create a personalized home fitness experience, offering users the ability to train with a virtual AI coach. 17. AI for network management NetOp: Proactive network operations platform predicts and fixes issues on cloud-managed enterprise networks, replacing tedious manual management, monitoring, and remediation. 18. AI for tools and community Dataloop: SaaS platform for end-to-end data management and quality data labeling, developing AI and machine learning models, enabling clients to shorten time to market and reduce costs. Data.World: Cloud-native SaaS platform offering the enterprise data catalog for the modern data stack. 19. AI for manufacturing 3D Signals: Adds Industry 4.0 capabilities to the tens of millions of pre-digital production machines that are not yet connected. Launchpad: Automated product manufacturing ecosystem, utilizing advanced simulation technologies and AI to substantially reduce manufacturing costs and enable onshoring. 20. AI for Space Edgybees: AI-powered software that improves geolocation and navigational accuracy by aligning satellite data and imagery with the physical world. … And this is just the beginning. Stay tuned to the OurCrowd website for further AI investment opportunities in these and other new verticals. This revolution is just getting started. Jon Medved is the CEO and Founder of OurCrowd, the global equity investment platform that gives individual accredited investors access to private market startup deals alongside top-tier VCs and institutions. Follow him on LinkedIn and Twitter. OurCrowd was started in 2013, driven by the idea that the business of building startups grows bigger and better when the global ‘crowd’ gains access to VC-level investment opportunities. Today, OurCrowd is a global venture and alternative investing platform that empowers institutions and individuals to invest and engage in emerging companies. OurCrowd vets and selects companies, invests its capital, and provides its global network with unparalleled access to co-invest and contribute connections, talent and deal flow. OurCrowd builds value for its portfolio companies throughout their lifecycles, providing mentorship, recruiting industry advisors, navigating follow-on rounds and creating growth opportunities through its network of multinational partnerships. Contact Details Lisa Graston lisa.graston@ourcrowd.com Company Website http://www.ourcrowd.com

January 18, 2024 09:00 AM Eastern Standard Time

Video
Article thumbnail News Release

Dermatologists-Founded Brand Skintensive Expands in 2024 with the Addition of Industry Veteran and Brand Acquisition

Skintensive

Skintensive, an award-winning and science-backed skincare brand founded by two Harvard-trained dermatologists, is thrilled to announce its plans for expansion in 2024. Known for its clinically-tested and top-selling Bruise Cream and a skincare range designed to support maturing and sensitive skin, Skintensive welcomes industry veteran, Dr. John Bartolone Ph.D., and acquires ScarSmart, a scar improvement and prevention brand. Bartolone joins Skintensive co-founders Anar Mikailov, M.D., FAAD, and Vladimir Ratushny, M.D., Ph.D., FAAD, as Chief Science Officer. With over 30 years of experience leading research and development labs in two of the world’s biggest personal care brands, Procter & Gamble and Unilever, Dr. Bartolone has launched numerous “first-of-its-kind” technologies and products in skincare and haircare. Pioneering core global science platforms, including anti-aging and skin lightening, Dr. Bartolone most recently launched Unilever’s first plant-based preservative system. Prior to pivoting to cosmetics, Dr. Bartolone was an Assistant Professor at the University of Connecticut, where he was awarded the “Best Paper of the Year” from the Society of Toxicology for ground-breaking research on Acetaminophen Hepatotoxicity. “I was impressed when I first met Dr. Mikailov and Dr. Ratushny in how they found an underserved, white space in the otherwise saturated skincare industry,” said Dr. Bartolone. “They’re seeing patients daily in clinics and using that direct patient feedback along with their expertise to create truly functional products. I’m honored to bring my experience and expertise to Skintensive as the brand continues expanding.” “Dr. Mikailov and I are humbled and excited for John Bartolone to join us at Skintensive,” said Dr. Ratushny. “Not only does he provide an encyclopedic insight into the skincare industry, his experience in product development, brand positioning, and creating breakthrough innovations is truly invaluable.” In addition to the appointment of John Bartolone, Skintensive is excited to announce the acquisition of Scar Smart, the makers of Scar Smart Silicone Scar Gel and Scar Smart Silicone Scar Sheets. Scar Smart is a proven silicone-based scar revision product line that will expand Skintensive’s product offering of functional skincare solutions. "We initially developed the Skintensive Bruise Cream to address acute and chronic bruising and solar purpura that is exceedingly common in our patients,” said Dr. Mikailov. “Those same patients also need options for the prevention and improvement of scars on their fragile skin. Now, the patients who trust our Skintensive brand will have access to an incredible product that dermatologists have recommended for many years." The Skintensive brand is carried by numerous board-certified dermatologist offices in the United States and will be exhibited at the 2024 American Academy of Dermatology conference in San Diego from March 7th through the 11th. Skintensive’s expansion in 2024 reflects the brand’s strong sales growth and its commitment to delivering cutting-edge, high-quality, expert-driven skincare solutions. With the addition of Dr. Bartolone and the acquisition of Scar Smart, Skintensive is well-positioned to continue its growth trajectory and strengthen its position through 2024 and beyond. For more information, visit Skintensive.com and @ skintensive on social media. ### About Skintensive Founded by two Harvard-trained dermatologists, Skintensive develops science-backed and clinically-tested skincare designed to support aging skin. Best known for the Skintensive Bruise Cream, the company ensures that each formula is grounded in research and crafted to perfection through rigorous testing. About Anar Mikailov, MD. FAAD Dr. Mikailov is a Harvard-trained dermatologist with an expertise in high-risk skin cancer and medical dermatology. He is the author of the world-famous Fitzpatrick’s Color Atlas and Synopsis of Clinical Dermatology 9th edition, the best-selling dermatology textbook. He is dual-boarded in both Internal Medicine and Dermatology. Recognized as a leader in consultative hospital dermatology, Dr. Mikailov has published extensively and presented internationally. He practices medical and consultative dermatology full-time in Rochester, NY. About Vladimir Ratushny, M.D. Ph.D. FAAD Dr. Ratushny is a Harvard-trained dermatologist and fellowship-trained Mohs surgeon. He is well-known for his expertise in Mohs surgery, high-risk skin cancer management, general dermatology, and hair transplantation. During the course of his Ph.D. at Fox Chase Cancer Center, Dr. Ratushny discovered two new drug combination therapies for cancer, one of which went on to be tested in a clinical trial for lung cancer patients. Dr. Ratushny’s original research, case reports, and review articles have been published in numerous peer-reviewed journals in areas ranging from skin cancer, drug resistance mechanisms, Lyme disease, allergic contact dermatitis, and medical humanities. Contact Details Glow Yang PR Gloria Yang +1 310-381-9964 Company Website https://www.skintensive.com

January 17, 2024 08:08 AM Eastern Standard Time

Image
1 ... 6061626364 ... 304